|Auflage||1. Auflage, 2007|
This volume will first review existing cholinesterase inhibitors prescribed for Alzheimer's disease (AD) patients followed by some target mechanisms with ongoing clinical trials. It offers a glimpse of what our future medicine cabinets may look like for AD patients. This volume is part of a series that covers hot topics of frontier research summarized by reputed scientists in the field.